In this review:
Low risk prostate cancer schedule comparison – hypofractionated vs conventional
Dose response relationship for hRT schedules
AAT combined with salvage RT following RP
New technology detects and analyses single CTCs
Adjuvant RT versus chemo-RT/chemo alone
Circulating cell-free DNA profiling in urothelial carcinoma
Conditional survival in patients with MT-GCT
Predicting recurrence in clear cell RCC patients
Clinical outcomes - 2L mRCC patients following premature discontinuation of VEG-TT. Toxicity vs progression
The METEOR analysis results
Please login below to download this issue (PDF)